Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78Zhiwen Gu, Aihua Sun, Kaikun Xu et al.|Proceedings of the National Academy of Sciences|2023Cited by 37
Knockdown of ferritin heavy chain (FTH) inhibits the migration of prostate cancer through reducing S100A4, S100A2, and S100P expressionCuixiu Lu, Man Zhang|Translational Cancer Research|2020Cited by 10